Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absolve, Aencco, ancillary, budgetary, BVI, capture, captured, caried, clawback, commensurate, copy, crucial, cyber, Dec, Demographic, Diego, disadvantage, discharge, EGC, fault, flexibility, forecast, fractional, greenhouse, hereunder, inflow, ISIN, Japanese, JP, legacy, lien, mail, merge, merged, noncompliance, outlined, outlook, overpayment, pendency, prepay, pronouncement, prudent, reallocate, recoupment, refine, resume, rotation, San, Seller, Sep, shifted, sooner, surrender, timelier, transparency, truthful, unanimously, unaudited, underperformance, Underrepresented, unrecoverable, UST, vii, viii, voluntarily, YOOV
Removed:
academia, Addendum, administrator, advertisement, aggregated, aggregation, aging, Airport, ambulatory, analog, ANOVA, antioxidation, antiviral, assembled, assigned, Assistant, bear, bearing, Bernstein, bioactive, Biochemistry, bone, boost, brand, Brazil, BSc, Bureau, CAGR, Cap, capability, career, Chamber, Chan, Chile, clarity, classifying, CMS, Compartment, computerized, concentrate, conserve, constant, consumption, continuously, correctly, counteracting, debarment, decade, decided, deed, deferring, delivering, demanding, density, dependence, depreciated, Deputy, digital, dioscorea, disability, discontinue, discontinued, diversifying, DOI, domestically, doubtful, EGCG, element, Emily, endometrial, endometrium, entirety, equally, Ernst, estradiol, Eternal, EUR, Eurasia, Euro, exchanging, experiment, exportation, extracted, FINRA, fit, Flat, floating, Fo, Fong, formalize, Geneva, GloboAsia, GnRH, green, guest, Hang, headquarter, heart, Histological, HKSTP, hormone, hourly, identifiable, Imperial, importation, indexed, ingredient, intramuscular, intraperitoneal, intrinsic, Iowa, Isabel, Jumpstart, Keith, Khan, Kut, labelling, language, leased, lesion, main, Malaysia, membership, menial, menopausal, menopause, Microbiology, mind, modern, modest, mortality, mother, movement, Municipal, Nanotechnology, NP, nutraceutical, nutritional, occurring, opened, opposita, outsource, ovarian, overlook, Oxford, paper, parachute, permanent, pharma, Pharmacy, Pinchuk, polyclinic, poorly, postmenopausal, powder, practiced, precaution, prepackaged, progesterone, proliferation, protein, radiation, reflection, refused, regional, remained, renovated, replaced, reproductive, researching, returned, revealed, Revision, Sabrina, saline, Scientist, secretion, sedentary, server, soluble, speaker, speed, spent, staffed, stimulate, successive, Sui, survived, Switzerland, synthetic, tail, Tan, tea, ticker, Tippie, Toronto, trajectory, Traumatology, untreated, Varengold, vascularization, viral, week, Wing, woman, women, Woo, word, yam, Young, Zealand
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.4 Appointment Letter Between the Company and Ian Huen (Executive Director), Dated November 20, 2023
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 15.1 Consent of Marcum Asia Cpas LLP
- 97.1 Policy for the Recovery of Erroneously Awarded Compensation
- Download Excel data file
- View Excel data file
APM similar filings
Filing view
External links
Exhibit 13.1
Certifications Pursuant to 18 U.S.C. Section 1350
Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Aptorum Group Limited (the “Company”), do hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 20-F for the year ended December 31, 2023 of the Company fully complies, in all material respects, with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 30, 2024 | |
/s/ Ian Huen | |
Ian Huen | |
Chief Executive Officer | |
(Principal Executive Officer) | |
/s/ Martin Siu | |
Martin Siu | |
Head of Finance | |
(Principal Financial Officer) |